News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
05 24 2010 Simplexa™ molecular RT-PCR test runs on the 3M Integrated CyclerQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today...
-
05 21 2010 Federal Funds and MedPlus Centergy Solution Accelerate New Mexico Health Information Collaborative's (NMHIC) Plan to Serve Two Million Patients StatewideNew Mexico is the first state to meet all requirements for strategic and operational planning as part of the American Recovery and Reinvestment...
-
05 06 2010 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its...
-
04 29 2010 The Quest Diagnostics Health Trends™ Report analyzes 195,000 H1N1 test results performed nationally since May 2009More than 99 percent of specimens tested for influenza were positive for H1N1 over approximately the past 11 months, according to a report...
-
04 21 2010 - Diluted earnings per share of $0.89, and revenues of $1.8 billion, unchanged from 2009Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the...
-
04 12 2010 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it...
-
04 06 2010 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it...
-
04 01 2010 Company Granted CEO Gold Standard™ Accreditation for Its Commitment to Employee Health and the Fight Against CancerQuest Diagnostics Incorporated (NYSE: DGX), the world's leader in cancer diagnostics, announced today that the company has received CEO Cancer Gold...
-
03 16 2010 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is...
-
03 09 2010 FDA-cleared test helps direct women to the most appropriate surgeon, promoting better outcomesOVA1™, the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation...